Clinical Trials Browser

Phase NA × Active not recruiting × Adenocarcinoma, Clear Cell × Clear all

NCT01582204 2025-08-05

Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma

Phase NA Active not recruiting

Kidney Neoplasms, Adenocarcinoma, Clear Cell